Article Details
Retrieved on: 2021-07-01 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SALT LAKE CITY, July 1, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here